University of Kentucky/Markey Cancer Center

Site:	University of Kentucky/Markey Cancer Center
Address:	800 Rose St. First Floor
City:	Lexington
State:	KY
Zip:	40536
Country:	USA

Phase	Trial	Trial Status [asc]	Site Status	Drug	NCT#
2	Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study	Active, not recruiting	Closed	CB-839	NCT03872427
2	Imatinib TDM (Therapeutic Drug Monitoring) in GIST	Recruiting	Active	Imatinib	NCT05493215